# Bioavailability of Nasal Naloxone and Injected Naloxone Compared

> **NCT02598856** · PHASE1 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 22 (actual)

## Conditions studied

- Drug Overdose

## Interventions

- **DRUG:** Intranasal (IN) naloxone 1x
- **DRUG:** Intranasal (IN) naloxone 2
- **DRUG:** Intravenous (IV) naloxone
- **DRUG:** Intramuscular (IM) naloxone

## Key facts

- **NCT ID:** NCT02598856
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598856, "Bioavailability of Nasal Naloxone and Injected Naloxone Compared". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02598856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*